Philochem AG
Teresa Hemmerle is a Senior Project Manager at Philochem AG, where Teresa has been working since May 2014. Prior to that, Teresa was a PhD student at ETH Zurich from January 2011 to February 2014. Teresa holds a Master of Science (MSc) in Pharmaceutical Sciences from ETH Zurich, which Teresa completed in 2010, and a Bachelor of Science (BSc) in Pharmaceutical Sciences, which Teresa completed in 2008.
Philochem AG
Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification.Philochem has discovered and development innovative methodologies in thefollowing areas:- design, construction and screening of DNA-encoded chemical libraries of unprecedented quality and size- development of small molecule-drug conjugates for cancer therapy- development of radiolabeled ligands for cancer imaging- development and application of chemical proteomics methodologies for the discovery of pharmaceutical targets- mass spectrometric characterization of MHC peptidomes for the development of innovative immunomodulatory strategiesThese technologies are integrated into drug discovery and product development programs.